- Search results for 2375240-92-7
Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
2 products were found matching "2375240-92-7"!
Close filters
Filter by:
No results were found for the filter!
Item number: BPS-83939-1
Efruxifermin, also known as AKR-001 or AMG-876, is an fusion protein composed of human IgG1 Fc domain linked to a modified human FGF21. Efruxifermin has prolonged half-life and enhanced receptor affinity compared with native human FGF21. Efruxifermin can be used for the research of non-alcoholic steatohepatitis...
| Keywords: | KLB, Beta-klotho, Klotho beta-like protein |
| Application: | Cellular assays |
| Host: | Human |
| Species reactivity: | human |
| CAS | 2375240-92-7 |
| MW: | 91.8 kD |
From 1,542.00€
*
Item number: TGM-T77175-50mg
Description: Efruxifermin, an Fc-FGF21 fusion protein consisting of a human IgG1 Fc domain linked to modified human FGF21, exhibits a prolonged half-life and enhanced receptor affinity compared to its native counterpart. It is utilized in researching non-alcoholic steatohepatitis [1].
| Application: | Targets fibroblast growth factor 21 (FGF21) |
| CAS | 2375240-92-7 |
Please request pricing for this article.
